EdPhar
EdPhar

Tag: bioequivalence issues

FDA Deficiency Letters in Generic Drug Applications: Common Findings & Fixes

FDA Deficiency Letters in Generic Drug Applications: Common Findings & Fixes

May, 27 2026

Discover the most common FDA deficiency letters in generic drug applications, including dissolution, impurities, and bioequivalence issues, and learn how to avoid costly delays.

categories
  • Health (199)
  • Manufacturing (4)
archives
  • May 2026 (12)
  • April 2026 (11)
  • March 2026 (11)
  • February 2026 (16)
  • January 2026 (28)
  • December 2025 (26)
  • November 2025 (20)
  • October 2025 (32)
  • September 2025 (15)
  • August 2025 (8)
  • July 2025 (14)
  • June 2025 (15)

Menu

  • About EdPhar
  • Terms of Service
  • Privacy Policy
  • Data Protection
  • Contact Us

©2026 edphar.com. All rights reserved